Tower Research Capital LLC (Trc) Centessa Pharmaceuticals PLC Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,861 shares of CNTA stock, worth $30,948. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,861
Previous 2,289
18.7%
Holding current value
$30,948
Previous $36,000
13.89%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding CNTA
# of Institutions
118Shares Held
124MCall Options Held
7KPut Options Held
220K-
Medicxi Ventures Management (Jersey) LTD20MShares$332 Million73.44% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$166 Million99.89% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$161 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.35MShares$106 Million3.55% of portfolio
-
First Light Asset Management, LLC Edina, MN5.81MShares$96.5 Million9.51% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.57B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...